These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26729968)

  • 1. Dose-dependent valproate-induced alopecia in patients with mental disorders.
    Tomita T; Goto H; Yoshida T; Tanaka K; Sumiya K; Kohda Y
    Indian J Pharmacol; 2015; 47(6):690-2. PubMed ID: 26729968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The valproate serum level in maintenance therapy for bipolar disorder in Japan.
    Machino A; Jitsuiki H; Okamoto Y; Izumitani S; Kimura Y; Suzuki K; Tanaka T; Inoue T; Koyama T; Wada K; Masaoka Y; Sasaki T; Yoshimura R; Nakamura J; Sumitan S; Ohmori T; Yamawaki S
    Hiroshima J Med Sci; 2013 Mar; 62(1):7-12. PubMed ID: 23600328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproate Intoxication in a Patient With Blood Valproate Levels Within Therapeutic Range.
    Smits JEMP; Wallenburg E; van Spanje A; van Luin M; Marijnissen RM
    J Clin Psychiatry; 2017 Apr; 78(4):e413-e414. PubMed ID: 28448701
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical correlates of response to valproate in geriatric inpatients.
    Niedermier JA; Nasrallah HA
    Ann Clin Psychiatry; 1998 Dec; 10(4):165-8. PubMed ID: 9988057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
    Bowden C; Göğüş A; Grunze H; Häggström L; Rybakowski J; Vieta E
    Int Clin Psychopharmacol; 2008 Sep; 23(5):254-62. PubMed ID: 18703934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid reversal of corticosteroid-induced mania with sodium valproate: a case series of 20 patients.
    Roxanas MG; Hunt GE
    Psychosomatics; 2012; 53(6):575-81. PubMed ID: 23157995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Valproate induced hypoactive delirium in a bipolar disorder patient with psychotic features].
    Ozen S; Bülbül I; Soyuçok E
    Turk Psikiyatri Derg; 2010; 21(1):79-84. PubMed ID: 20204907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alopecia and mood stabilizer therapy.
    McKinney PA; Finkenbine RD; DeVane CL
    Ann Clin Psychiatry; 1996 Sep; 8(3):183-5. PubMed ID: 8899137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania.
    Allen MH; Hirschfeld RM; Wozniak PJ; Baker JD; Bowden CL
    Am J Psychiatry; 2006 Feb; 163(2):272-5. PubMed ID: 16449481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Open randomized comparative twelve-week study of lithium and valproate in manic episode].
    Mosolov SN; Kostiukova EG; Kapiletti SG; Belen'kaia DV; Shafarenko AA; Fedotov DD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(11):47-52. PubMed ID: 20032954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.
    Bowden CL; Mosolov S; Hranov L; Chen E; Habil H; Kongsakon R; Manfredi R; Lin HN
    Int Clin Psychopharmacol; 2010 Mar; 25(2):60-7. PubMed ID: 20101186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of valproic acid in patients with bipolar disorder.
    Vasudev K; Das S; Goswami U; Tayal G
    J Psychopharmacol; 2001 Sep; 15(3):187-90. PubMed ID: 11565626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does valproic acid warrant therapeutic drug monitoring in bipolar affective disorder?
    Haymond J; Ensom MH
    Ther Drug Monit; 2010 Feb; 32(1):19-29. PubMed ID: 19901867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of valproate-induced alopecia.
    Fatemi SH; Calabrese JR
    Ann Pharmacother; 1995 Dec; 29(12):1302. PubMed ID: 8672845
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous valproate loading in acutely manic and depressed bipolar I patients.
    Grunze H; Erfurth A; Amann B; Giupponi G; Kammerer C; Walden J
    J Clin Psychopharmacol; 1999 Aug; 19(4):303-9. PubMed ID: 10440456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate-induced encephalopathy related to concurrent antimanic medications.
    Trojak B; de la Gastine B; Dollfus S
    J Neuropsychiatry Clin Neurosci; 2011; 23(1):E22-3. PubMed ID: 21304120
    [No Abstract]   [Full Text] [Related]  

  • 17. Valproate in bipolar disorder: 2000 onwards.
    Bowden CL; Singh V
    Acta Psychiatr Scand Suppl; 2005; (426):13-20. PubMed ID: 15833096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, drug interactions, and tolerability of valproate.
    DeVane CL
    Psychopharmacol Bull; 2003; 37 Suppl 2():25-42. PubMed ID: 14624231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium valproate induced acute pancreatitis in a bipolar disorder patient: a case report.
    Huang W; Ren X; Shen F; Xing B
    BMC Pharmacol Toxicol; 2019 Nov; 20(1):71. PubMed ID: 31783774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute antimanic efficacy and safety of intravenous valproate loading therapy: an open-label study.
    Jagadheesan K; Duggal H; Gupta S; Basu S; Ranjan S; Sandil R; Akhtar S; Nizamie SH
    Neuropsychobiology; 2003; 47(2):90-3. PubMed ID: 12707491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.